Latest Regulatory News

Enlitic has locked in binding commitments for a conditional A$15 million capital raise alongside a convertible note conversion, setting the stage for a clearer path to cashflow break-even and accelerated rollout of its SaaS platform.

EMC Gold appoints Agne Ahlenius as CEO, reinforcing its strategic pivot to Spain with leadership focused on advancing the Salave Gold Project’s permitting and stakeholder engagement.

Germany’s Hesse State Office has issued new GMP guidance that questions the viability of fragmented medicinal cannabis supply chains, reinforcing ECS Botanics’ integrated manufacturing approach and potentially tightening market supply.

Starpharma has reached a key milestone in its collaboration with Radiopharm Theranostics, unlocking a $0.5 million option fee and advancing the partnership toward a potential $91 million licensing deal.

Riversgold has been granted a 21-year mining lease for its Northern Zone Gold Project near Kalgoorlie, clearing a major hurdle for development and triggering full funding from Mega Resources under a profit-sharing agreement.

KGL Resources has launched a $120 million entitlement offer at $0.20 per share, part of a $300 million capital raise to fund the Jervois Copper Project. The offer is underwritten except for pre-commitments from major shareholders, with new shares expected to be issued late July.

Osmond Resources is advancing its Orión EU Critical Minerals Project with imminent assay results, upcoming resource estimates, and a secondary listing on the Madrid Stock Exchange, aiming to become the EU's first producer of rare earth-bearing minerals.

Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.

Emerald Resources has locked in major mining contracts with MACA Mining for its Dingo Range project in Western Australia and extended operations at its Okvau Gold Mine in Cambodia, underpinning its growth strategy across two continents.

Racura Oncology has secured Bellberry HREC approval for its HARNESS-1 lung cancer trial, enabling expansion to additional Australian sites including Chris O’Brien Lifehouse and Austin Health, setting the stage for accelerated patient enrolment.

Mamba Exploration has significantly increased its landholding at the Meeka East Gold Project through acquisition and new licence pegging, setting the stage for reverse circulation drilling pending heritage approvals.

OncoSil Medical has submitted its Humanitarian Device Exemption application to the FDA for its OncoSil™ device targeting distal cholangiocarcinoma, entering the final review phase with a decision expected within 45 days.